MetLife executive exercises options, sells 21,312 shares

MetLife EVP & Chief Risk Officer Marlene Debel reported option exercises and share sales in common stock.

Rhea-AI Filing Summary

MetLife EVP & Chief Risk Officer Marlene Debel reported option exercises and share sales in common stock. On June 1, 2026, she exercised employee stock options to acquire 10,712 shares at $45.50 and 10,600 shares at $46.85 per share. The same day, she completed an open‑market sale of 21,312 shares at a weighted average price of $81.5889, with individual trade prices between $81.57 and $81.65. Following these transactions, she directly owns 154,380 shares of MetLife common stock.

Insights

Equity compensation analyst

Routine option exercises paired with a moderate insider sale.

EVP & Chief Risk Officer Marlene Debel exercised employee stock options for a total of 21,312 shares at strike prices of $45.50 and $46.85, then sold the same number of shares in open‑market trades at a weighted average of $81.5889.

The filing shows a classic exercise‑and‑sell pattern, converting option value into cash while maintaining a substantial remaining equity stake of 154,380 common shares. With 0% reported remaining employee stock options in this excerpt, the visible derivative position tied to these grants has been fully exercised.

This activity represents a net share sale but still leaves a large direct holding, suggesting ongoing alignment with shareholders. The trades were executed across multiple prices between $81.57 and $81.65; no Rule 10b5‑1 trading plan is referenced in the provided text.

Insider Trade Summary

Exercise and Sale: 21,312 shares ($755K approx. pre-tax spread)

Exercise and Sale 5 txns

Insider DEBEL MARLENE

Role EVP & Chief Risk Officer

Sold 21,312 shs ($1.74M)

Approx. gross sale proceeds $1.74M

Approx. exercise cost $984K

Approx. pre-tax spread $755K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Options (right to buy)	10,600	$0.00	$0.00
Exercise	Employee Stock Options (right to buy)	10,712	$0.00	$0.00
Exercise	Common Stock	10,600	$46.85	$497K
Exercise	Common Stock	10,712	$45.50	$487K
Sale	Common Stock	21,312	$81.5889	$1.74M

Holdings After Transaction: Employee Stock Options (right to buy) — 0 contracts (Direct); Common Stock — 154,380 shares (Direct)

Footnotes (3)

1. F1. The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
2. F2. The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020.
3. F3. The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021.

Key Figures

Shares sold: 21,312 shares Sale price (weighted average): $81.5889 per share Options exercised at $45.50: 10,712 shares +3 more

6 metrics

Shares sold 21,312 shares Open-market sale of MetLife common stock on June 1, 2026

Sale price (weighted average) $81.5889 per share Weighted average for 21,312 shares sold; trades between $81.57 and $81.65

Options exercised at $45.50 10,712 shares Employee stock options exercised into common stock

Options exercised at $46.85 10,600 shares Employee stock options exercised into common stock

Shares owned after transactions 154,380 shares Direct MetLife common stock ownership reported post-transaction

Total options exercised 21,312 shares Combined from two employee stock option grants

Key Terms

Employee Stock Options (right to buy), weighted average price, open market transactions, derivative security, +1 more

5 terms

Employee Stock Options (right to buy) financial

"security_title: "Employee Stock Options (right to buy)""

weighted average price financial

"The price reported is the weighted average price of the aggregate number of shares sold"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market transactions financial

"shares sold in multiple open market transactions"

Open market transactions are the buying and selling of a company’s shares or other securities conducted on public exchanges or through the wider market rather than through private deals or negotiated placements. They matter to investors because these trades change supply and demand in real time—like shoppers affecting a store’s inventory—and so can move prices, signal management or investor sentiment, affect liquidity, and alter ownership stakes that influence future returns and risk.

derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

installments financial

"The options became exercisable in three substantially equal installments"

Installments are a series of scheduled partial payments that together cover a larger amount owed or due, like paying for a purchase or loan in weekly or monthly pieces rather than all at once. For investors, installments matter because they change when cash moves between parties, affect a company’s or counterparty’s short-term cash flow and risk of missed payments, and can influence valuation or perceived financial stability much like spreading the cost of a car over monthly payments.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MetLife (MET) executive Marlene Debel do in this Form 4?

Marlene Debel, MetLife’s EVP & Chief Risk Officer, exercised employee stock options for 21,312 common shares and sold 21,312 shares in open‑market trades on June 1, 2026. These transactions convert option value into cash while leaving her with a sizable remaining shareholding.

How many MetLife (MET) shares did Marlene Debel sell and at what price?

She sold 21,312 MetLife common shares in open‑market transactions at a weighted average price of $81.5889 per share. Individual trades occurred between $81.57 and $81.65, according to the weighted‑average pricing footnote included in the filing.

What stock options did Marlene Debel exercise in MetLife (MET)?

She exercised employee stock options covering 10,712 MetLife common shares at a $45.50 strike and 10,600 shares at a $46.85 strike. These options had become exercisable in three substantially equal installments across 2018–2021, as described in the footnotes.

How many MetLife (MET) shares does Marlene Debel own after these transactions?

Following the June 1, 2026 option exercises and share sale, Marlene Debel directly owns 154,380 MetLife common shares. This post‑transaction figure comes from the Form 4 and shows she retains a significant equity stake after converting some option value to cash.

Were Marlene Debel’s MetLife (MET) trades done in the open market?

Yes. The Form 4 identifies her disposition as an open‑market sale and notes the price reported is a weighted average of multiple transactions. The shares were sold at prices between $81.57 and $81.65 per share on June 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEBEL MARLENE

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Risk Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		M		10,600	A	$46.85	164,980	D
Common Stock	06/01/2026		M		10,712	A	$45.5	175,692	D
Common Stock	06/01/2026		S		21,312	D	$81.5889(1)	154,380	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (right to buy)	$46.85	06/01/2026		M			10,600	(2)	02/27/2027	Common Stock	10,600	$0	0	D
Employee Stock Options (right to buy)	$45.5	06/01/2026		M			10,712	(3)	03/01/2028	Common Stock	10,712	$0	0	D

Explanation of Responses:

1. The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

2. The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020.

3. The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021.

Remarks:

	/s/ Morgan Keehner-Jones Mayes, Attorney-in-fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)